Astrocyte Research

Astrocyte Research delivers real-time global market forecasts and alerts. We use machine learning and domain expertise to identify changes in correlation, regimes, and the structure of risks within global markets. Financial advisors rely on our Portformer fund intelligence solution to save time and earn more for their clients. Discretionary investors, systematic funds and portfolio advisors rely on our Breakpoint platform for deep insights that constantly test their strategy's assumptions. Astrocyte was founded in 2014 by MIT Alumnus and former Global Macro Portfolio Manager Sean Kruzel. Sean lends the platform his special expertise in economics, mathematics, and software engineering. One-Screen Simplicity Explore a whole universe of funds without juggling tabs. Enjoy full functionality on all your devices. Opinionated & Actionable Just type in a ticker and see our Top 10 alternative funds in seconds. Select and compare based on returns, risk, and fees. Unbiased Analysis Cut through marketing jargon and industry biases. Portformer™ compares investments based on efficiency, not reputation. Serious Fee Savings Grow your AUM the easy way—with investments that earn their fees. Portformer saves 30bps on average. Portformer is an Astrocyte Research, Inc. product. Astrocyte was founded in 2014 by portfolio manager and MIT grad Sean Kruzel to create next-generation solutions for investment professionals.

Website

http://portformer.com

External link for Astrocyte Research

Industry

Financial Services

Company size

2-10 employees

Headquarters

Boston, Massachusetts

Founded

2014

Specialties

mutual funds, etfs, forecasting, fee analysis, portfolio management, financial advisor, ria, and risk management